Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ERCC3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ERCC3 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, risk factor for. Associated with ALS, Als, Carcinoma. Connected to 35 entities in the SciDEX knowledge graph.
| Gene Symbol | ERCC3 |
| Full Name | ERCC3 |
| Chromosome | 19q13.32. |
| Protein Type | Gene |
| Function | is a DNA repair gene located on chromosome 19q13. |
| Primary Expression | all human tissues, including: - Brain: neurons, astrocytes, microglia, oligodendroc |
| Molecular Weight | 89 kDa |
| Amino Acids | 782 aa |
| Exons | 17 |
| Pathways | Akt, Mtor, PI3K-AKT-mTOR signaling, Pi3K |
| NCBI Gene ID | Search NCBI |
| GeneCards | ERCC3 |
| Human Protein Atlas | ERCC3 |
| Associated Diseases | Als, Carcinoma, Cirrhosis |
| Interactions | CEBPB, PI3K, EGFR, MTOR, CYP3A4, AKT |
| KG Connections | 43 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
ERCC3["<b>ERCC3</b>"]
Cirrhosis{"Cirrhosis"}
ERCC3 -->|"activates"| Cirrhosis
Carcinoma{"Carcinoma"}
ERCC3 -->|"activates"| Carcinoma
Ms{"Ms"}
ERCC3 -->|"activates"| Ms
Als{"Als"}
ERCC3 -->|"activates"| Als
ERCC3 -->|"associated with"| Als
ERCC3 -->|"associated with"| Carcinoma
ERCC3 -->|"associated with"| Cirrhosis
ALS{"ALS"}
ERCC3 -->|"activates"| ALS
CEBPB["CEBPB"]
ERCC3 -->|"activates"| CEBPB
Pi3K(["Pi3K"])
ERCC3 -->|"activates"| Pi3K
Mtor(["Mtor"])
ERCC3 -->|"activates"| Mtor
Akt(["Akt"])
ERCC3 -->|"activates"| Akt
EGF["EGF"]
EGF -->|"activates"| ERCC3
CYP3A4["CYP3A4"]
CYP3A4 -->|"activates"| ERCC3
PDK1["PDK1"]
PDK1 -->|"activates"| ERCC3
MTOR["MTOR"]
MTOR -->|"activates"| ERCC3
EGFR["EGFR"]
EGFR -->|"activates"| ERCC3
CYP1A2["CYP1A2"]
CYP1A2 -->|"activates"| ERCC3
AKT["AKT"]
AKT -->|"activates"| ERCC3
CEBPB -->|"activates"| ERCC3
PI3K["PI3K"]
PI3K -->|"activates"| ERCC3
CCL2["CCL2"]
CCL2 -->|"activates"| ERCC3
style ERCC3 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Hepatocellular Carcinoma | risk_factor_for | disease | 0.85 |
| Hepatocellular Carcinoma | contributes_to | disease | 0.80 |
| Cirrhosis | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Cirrhosis | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| CEBPB | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| CYP3A4 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PDK1 | activates | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| PSEN2 | associated_with | gene | 0.60 |
| Pi3K | activates | pathway | 0.60 |
| Mtor | activates | pathway | 0.60 |
| Akt | activates | pathway | 0.60 |
| Mtor | associated_with | pathway | 0.60 |
| CYP1A2 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| ONCOGENES | activates | gene | 0.60 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.60 |
| Macrophage | expressed_in | cell_type | 0.55 |
| NAFLD | activates | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| EGF | activates | gene | 0.60 |
| CYP3A4 | activates | gene | 0.60 |
| PDK1 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| CEBPB | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| CHKA | activates | gene | 0.60 |
| CCND3 | associated_with | gene | 0.60 |
| CYP1A2 | activates | gene | 0.60 |
| CCL2 | activates | gene | 0.60 |
| ONCOGENES | activates | gene | 0.60 |
| Pi3K | activates | pathway | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||